NEW YORK (GenomeWeb News) – OriGene Technologies has acquired Marligen Biosciences, a privately held seller of DNA and RNA purification kits and multiplex assays for genotyping, microRNA profiling, and transcription factor activity analysis.

Rockville, Md.-based OriGene makes gene cloning and gene expression tools. OriGene raised $6.5 million earlier this year in a private equity financing to support its acquisition of Shenzhen P&A Biotech, a manufacturer of monoclonal antibodies.

The firms did not disclose the purchase price.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.